Previous 10 | Next 10 |
home / stock / lbtsf / lbtsf news
Almirall, S.A. (LBTSF) Q4 2021 Earnings Conference Call February 21, 2022 4:00 AM ET Company Participants Pablo Divasson - Head of Investor Relations Gianfranco Nazzi - Chief Executive Officer Karl Ziegelbauer - Chief Scientific Officer Mike McClellan - Chief Financial Officer Conference Call...
The following slide deck was published by Almirall, S.A. in conjunction with their 2021 Q4 earnings call. For further details see: Almirall, S.A. 2021 Q4 - Results - Earnings Call Presentation
Dr. Jorge Gallardo Ballart announces his intention to retire from his positions of President of the Board of Directors and Board member of Almirall The resignation will be effective as of the end of the General Shareholders Meeting of Almirall, S.A. that will take place next 6 M...
Almirall's Full-Year 2021 Results : Almirall delivers high end of the 2021 upgraded guidance with solid performance from growth drivers PR Newswire BARCELONA, Spain , Feb. 21, 2022 /PRNewswire/ -- Almirall delivered at the high end of its upgraded guidanc...
The following slide deck was published by Almirall, S.A. in conjunction with their 2021 Q3 earnings call. For further details see: Almirall, S.A. 2021 Q3 - Results - Earnings Call Presentation
Almirall's (LBTSF) Q3 2021 Earnings Conference Call November 15, 2021, 04:00 AM ET Company Participants Pablo Divasson - Head of Investor Relations Gianfranco Nazzi - Chief Executive Officer Karl Ziegelbauer - Chief Scientific Officer Mike McClellan - Chief Financial Officer Conference Call P...
Almirall delivers solid nine months 2021 results and tightens its upgraded guidance PR Newswire BARCELONA, Spain , Nov. 15, 2021 /PRNewswire/ -- Strong Core business performance with growth in Core Net Sales €601.7 MM (+6.2% year-on-year) and Core ...
Almirall U.S. Supports The Skin Cancer Foundation's Mobile Skin Cancer Screening Program PR Newswire - The Foundation's Destination Healthy Skin RV visits communities around the U.S. to raise skin cancer awareness MALVERN, Pa. , Nov. 8, ...
Athenex's (NASDAQ:ATNX) partner, Almirall (OTC:LBTSF) has launched Klisyri (tirbanibulin) in Germany and the U.K. Shares up 3.7% premarket at $3.34. Klisyri received approval by the European Commission and the U.K.'s regulatory agency in July and August of 2021, respe...
Almirall, S.A. (LBTSF) Q2 2021 Earnings Conference Call July 26, 2021 4:00 AM ET Company Participants Pablo Divasson – Head of Investor Relations Gianfranco Nazzi – Chief Executive Officer Karl Ziegelbauer – Chief Scientific Officer Mike McClellan – Chief Financial...
News, Short Squeeze, Breakout and More Instantly...
Almirall Sa Ord Company Name:
LBTSF Stock Symbol:
OTCMKTS Market:
Strong growth trajectory maintained with Net Sales increase of 6.7% to a total of €497.2 MM, EBITDA of €104.5 MM (+3.2% YoY) driven by increased overall sales and strong performance of biologics portfolio Biologics continue to be key growth engines for Almirall: Ebglyss ...
Lebrikizumab is recommended by NICE for the use in moderate to severe Atopic Dermatitis in patients 12 years and over when their condition has not responded to at least 1 systemic immunosuppressant, or when these treatments are not suitable Following approval of the European Commission (Octob...
Almirall’s sustainability strategy focuses on five pillars: Planet, People, Patients, Partners and Principles defining clear targets and measurements Among other commitments, Almirall aims to – by 2030 - reduce absolute direct greenhouse gas emissions by 50%, minimize the ge...